People diagnosed with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) frequently report changes to cognitive functioning as the disease progresses. This is particularly a symptom experienced in PSP. Mild cognitive deficits can be present at time of diagnosis and are often in the areas of processing, organization and attention. Acknowledging changes in memory and thinking can be scary, but ignoring them only leads to more challenges with care and safety. Neuropsychological evaluations provide objective and comprehensive assessments of cognitive strengths and weaknesses, as well as systematically investigate behavioral and psychiatric disturbances that may also be present, such as anxiety or personality changes. In this webinar, Dr. Travis Turner, neuropsychologist at the CurePSP Center of Care at the Medical University of South Carolina, will provide a brief overview of the cognitive changes associated with PSP, CBD and MSA, describe the neuropsychological evaluation process and discuss how the information obtained informs diagnosis, prognosis and treatment planning.
11 дек 2022
